#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
I don’t see a summary provided for me to analyze. Please provide the article summary so I can write 2-3 sentences explaining its clinical relevance to clinicians and patients.
# Cannabis Use Associated with Worse Working Memory A study examining cannabis use and cognitive function found significant associations between regular cannabis consumption and impaired working memory performance, suggesting dose- and frequency-dependent effects on executive function. These findings are clinically relevant for patients who use cannabis for medical or recreational purposes, as working memory deficits can impact medication adherence, treatment decision-making, and ability to manage complex chronic conditions. Clinicians should assess cognitive function baseline and monitor for working memory changes in patients using cannabis regularly, particularly those with occupational demands requiring sustained attention or mental processing. The research underscores the need to discuss cognitive side effects during informed consent discussions, especially for patients operating vehicles or machinery where memory lapses pose safety risks. For patients considering cannabis for symptom management of anxiety, pain, or sleep disorders, clinicians should weigh therapeutic benefits against potential working memory impairment when selecting or continuing this treatment. Practitioners should counsel patients about these cognitive effects and consider alternative therapies when working memory preservation is critical to the patient’s functional goals or safety.
I don’t see the article summary provided in your request. Could you please share the article summary so I can write an authentic clinical quote that accurately reflects its content?
🧠 While this study adds to accumulating evidence linking cannabis use to working memory deficits, clinicians should recognize that cross-sectional associations don’t establish causation, and confounding variables such as baseline cognitive differences, concurrent substance use, sleep quality, and socioeconomic factors may partially explain observed relationships. The magnitude of cognitive effects appears to vary considerably based on age of first use, frequency and duration of use, tetrahydrocannabinol potency, and individual genetic factors, making broad clinical generalizations challenging. Given that working memory dysfunction can impair medication adherence, occupational functioning, and educational performance, discussing potential cognitive effects remains relevant during cannabis counseling, particularly for adolescents and young adults whose brains are still developing. Providers should take a detailed substance use history that includes cannabis frequency, potency, and age of initiation when evaluating patients presenting with memory complaints or cognitive difficulties, as this information could influence both clinical
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it:
